Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy.
about
Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Modeling the receptor pharmaco ...... nist for cancer immunotherapy.
@ast
Modeling the receptor pharmaco ...... nist for cancer immunotherapy.
@en
type
label
Modeling the receptor pharmaco ...... nist for cancer immunotherapy.
@ast
Modeling the receptor pharmaco ...... nist for cancer immunotherapy.
@en
prefLabel
Modeling the receptor pharmaco ...... nist for cancer immunotherapy.
@ast
Modeling the receptor pharmaco ...... nist for cancer immunotherapy.
@en
P2093
P2860
P1433
P1476
Modeling the receptor pharmaco ...... onist for cancer immunotherapy
@en
P2093
John Langowski
Jonathan Zalevsky
Michael Eldon
Peter Kirk
Samira Khalili
Stephen K Doberstein
Thomas Chang
Vidula Dixit
Werner Rubas
P2860
P304
P356
10.1371/JOURNAL.PONE.0179431
P407
P577
2017-07-05T00:00:00Z